BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 12795046)

  • 1. Epidemiology of non-steroidal anti-inflammatory drugs and cancer.
    Baron JA
    Prog Exp Tumor Res; 2003; 37():1-24. PubMed ID: 12795046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review).
    Harris RE; Beebe-Donk J; Doss H; Burr Doss D
    Oncol Rep; 2005 Apr; 13(4):559-83. PubMed ID: 15756426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-aspirin non-steroidal anti-inflammatory drugs for the primary chemoprevention of non-gastrointestinal cancer: summary of evidence.
    Silva MT; Galvao TF; Zimmerman IR; Pereira MG; Lopes LC
    Curr Pharm Des; 2012; 18(26):4047-70. PubMed ID: 22632754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin and NSAIDs: effects in breast and ovarian cancers.
    Crew KD; Neugut AI
    Curr Opin Obstet Gynecol; 2006 Feb; 18(1):71-5. PubMed ID: 16493264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement.
    Cuzick J; Otto F; Baron JA; Brown PH; Burn J; Greenwald P; Jankowski J; La Vecchia C; Meyskens F; Senn HJ; Thun M
    Lancet Oncol; 2009 May; 10(5):501-7. PubMed ID: 19410194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
    Sandler RS
    Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer.
    Farrow DC; Vaughan TL; Hansten PD; Stanford JL; Risch HA; Gammon MD; Chow WH; Dubrow R; Ahsan H; Mayne ST; Schoenberg JB; West AB; Rotterdam H; Fraumeni JF; Blot WJ
    Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):97-102. PubMed ID: 9488582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-steroidal anti-inflammatory drugs and chemoprevention of cancer.
    Vainio H; Morgan G
    Ann Chir Gynaecol; 2000; 89(3):173-6. PubMed ID: 11079784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas.
    Huls G; Koornstra JJ; Kleibeuker JH
    Lancet; 2003 Jul; 362(9379):230-2. PubMed ID: 12885487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
    Baandrup L
    Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer and nonsteroidal anti-inflammatory drugs.
    Smalley WE; DuBois RN
    Adv Pharmacol; 1997; 39():1-20. PubMed ID: 9160111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin and other nonsteroid anti-inflammatory drugs as cancer-preventive agents.
    Greenberg ER; Baron JA
    IARC Sci Publ; 1996; (139):91-8. PubMed ID: 8923021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis.
    González-Pérez A; García Rodríguez LA; López-Ridaura R
    BMC Cancer; 2003 Oct; 3():28. PubMed ID: 14588079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin and cancer risk: an update to 2001.
    Bosetti C; Gallus S; La Vecchia C
    Eur J Cancer Prev; 2002 Dec; 11(6):535-42. PubMed ID: 12457105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
    Gill S; Sinicrope FA
    Semin Oncol; 2005 Feb; 32(1):24-34. PubMed ID: 15726503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention.
    DuBois RN; Giardiello FM; Smalley WE
    Gastroenterol Clin North Am; 1996 Dec; 25(4):773-91. PubMed ID: 8960892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II.
    Moyad MA
    Semin Urol Oncol; 2001 Nov; 19(4):306-16. PubMed ID: 11769882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NSAIDs and gastrointestinal cancer prevention.
    Jolly K; Cheng KK; Langman MJ
    Drugs; 2002; 62(6):945-56. PubMed ID: 11929340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis.
    Corley DA; Kerlikowske K; Verma R; Buffler P
    Gastroenterology; 2003 Jan; 124(1):47-56. PubMed ID: 12512029
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.